Multifunctional bone morphogenetic protein system in endocrinology

Acta Medica Okayama

Volumn 67, Issue 2, 2013, Pages 75-86

  Otsuka, Fumio ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Bone morphogenetic protein; Folliculogenesis; Pituitary adenoma; Steroidogenesis; Transforming growth factor

Indexed keywords

BONE MORPHOGENETIC PROTEIN; STEROID; TRANSFORMING GROWTH FACTOR;

ADENOMA; ARTICLE; ENDOCRINOLOGY; FEMALE; HUMAN; HYPOPHYSIS TUMOR; OVARY FOLLICLE; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADENOMA; BONE MORPHOGENETIC PROTEINS; ENDOCRINOLOGY; FEMALE; HUMANS; OVARIAN FOLLICLE; PITUITARY NEOPLASMS; STEROIDS; TRANSFORMING GROWTH FACTORS;

EID: 84878645737     PISSN: 0386300X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (100)

1. Urist MR: Bone: Formation by autoinduction. Science (1965) 150: 893-899.
2. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ Kriz RW, Hewick RM and Wang EA: Novel regulators of bone formation: Molecular clones and activities. Science (1988) 242: 1528-1534.
3. Griffith DL, Keck PC, Sampath TK, Rueger DC and Carlson WD Three-dimensional structure of recombinant human osteogenic protein 1: Structural paradigm for the transforming growth factor 6 superfamily. Proc Natl Acad Sci USA (1996) 93: 878-883.
4. Kawabata M and Miyazono K: Bone morphogenetic proteins; in Canalis E (ed): Skeletal growth factors. Philadelphia, Lippincott Williams & Wilkins, 2000, pp 269-290
5. Wagner DO, Sieber C, Bhushan R, Borgermann JH, Graf D and Knaus P: Bmps: From bone to body morphogenetic proteins. Sci Signal (2010) 3: mr1.
6. Matsumoto Y, Otsuka F, Hino J, Miyoshi T, Takano M, Miyazato M, Makino H and Kangawa K: Bone morphogenetic protein-3b (bmp-3b) inhibits osteoblast differentiation via smad2/3 pathway by counteracting smad1/5/8 signaling. Mol Cell Endocrinol (2012) 350: 78-86.
7. Hogan BLM: Bone morphogenetic proteins: Multifunctional regulators of vertebrate development. Genes Dev (1996) 10: 1580-1594.
8. Lyons KM, Pelton RW and Hogan BL: Organogenesis and pattern formation in the mouse: Rna distribution patterns suggest a role for bone morphogenetic protein-2a (bmp-2a). Development (1990) 109: 833-844.
9. Yamanaka R, Otsuka F, Nakamura K, Yamashita M, Otani H Takeda M, Matsumoto Y, Kusano KF, Ito H and Makino H Involvement of the bone morphogenetic protein system in endothe-lin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension. Hypertens Res (2010) 33: 435-445.
10. Otani H, Otsuka F, Inagaki K, Takeda M, Miyoshi T, Suzuki J. Mukai T, Ogura T and Makino H: Antagonistic effects of bone morphogenetic protein-4 and -7 on renal mesangial cell proliferation induced by aldosterone through mapk activation. Am J Physiol Renal Physiol (2007) 292: F1513-1525.
11. Suzuki J, Otsuka F, Matsumoto Y, Inagaki K, Miyoshi T, Takeda M Tsukamoto N, Nakamura E, Ogura K and Makino H: Enhanced expression of bone morphogenetic protein system in aldosterone-treated mouse kidneys. Hypertens Res (2012) 35: 312-317
12. Otsuka F: Multiple endocrine regulation by bone morphogenetic protein system. Endocr J (2010) 57: 3-14.
13. Mukai T, Otsuka F, Otani H, Yamashita M, Takasugi K, Inagaki K. Yamamura M and Makino H: Tnf-alpha inhibits bmp-induced osteoblast differentiation through activating sapk/jnk signaling. Biochem Biophys Res Commun (2007) 356: 1004-1010.
14. Yamashita M, Otsuka F, Mukai T, Otani H, Inagaki K, Miyoshi T. Goto J, Yamamura M and Makino H: Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic pro-teins-2-induced osteoblast differentiation by regulating smad signaling and ras/rho-mitogen-activated protein kinase pathway. J Endocrinol (2008) 196: 601-613.
15. Matsumoto Y, Otsuka F, Takano M, Mukai T, Yamanaka R Takeda M, Miyoshi T, Inagaki K, Sada KE and Makino H Estrogen and glucocorticoid regulate osteoblast differentiation through the interaction of bone morphogenetic protein-2 and tumor necrosis factor-alpha in c2c12 cells. Mol Cell Endocrinol (2010) 325: 118-127.
16. Takano M, Otsuka F, Matsumoto Y, Inagaki K, Takeda M Nakamura E, Tsukamoto N, Miyoshi T, Sada KE and Makino H Peroxisome proliferator-activated receptor activity is involved in the osteoblastic differentiation regulated by bone morphogenetic proteins and tumor necrosis factor-alpha. Mol Cell Endocrinol (2012) 348: 224-232.
17. Liu F, Ventura F, Doody J and Massague J: Human type ii receptor for bone morphogenic proteins (bmps): Extension of the two-kinase receptor model to the bmps. Mol Cell Biol (1995) 15: 3479-3486.
18. Miyazono K, Kusanagi K and Inoue H: Divergence and convergence of tgf-beta/bmp signaling. J Cell Physiol (2001) 187: 265-276.
19. Eppig JJ: Oocyte control of ovarian follicular development and function in mammals. Reproduction (2001) 122: 829-838
20. Gilchrist RB, Ritter LJ, Myllymaa S, Kaivo-Oja N, Dragovic RA: Hickey TE, Ritvos O and Mottershead DG: Molecular basis of oocyte-paracrine signalling that promotes granulosa cell proliferation. J Cell Sci (2006) 119: 3811-3821
21. Shimasaki S, Moore RK, Erickson GF and Otsuka F: The role of bone morphogenetic proteins in ovarian function. Reprod Suppl (2003) 61: 323-337.
22. Shimasaki S, Moore RK, Otsuka F and Erickson GF: The bone morphogenetic protein system in mammalian reproduction. Endocr Rev(2004) 25: 72-101.
23. Findlay JK, Drummond AE, Dyson ML, Baillie AJ, Robertson DM and Ethier JF: Recruitment and development of the follicle: The roles of the transforming growth factor-beta superfamily. Mol Cel Endocrinol (2002) 191: 35-43.
24. Erickson GF and Shimasaki S: The spatiotemporal expression pattern of the bone morphogenetic protein family in rat ovary eel types during the estrous cycle. Reprod Biol Endocrinol (2003) 1: 9
25. Drummond AE, Dyson M, Le MT, Ethier JF and Findlay JK Ovarian follicle populations of the rat express tgf-beta signalling pathways. Mol Cell Endocrinol (2003) 202: 53-57.
26. Otsuka F, McTavish K and Shimasaki S: Integral role of gdf-9 and bmp-15 in ovarian function. Mol Reprod Dev (2011) 78: 9-21
27. Otsuka F and Inagaki K: Unique bioactivities of bone morphogenetic proteins in regulation of reproductive endocrine functions. Reprod Med Biol (2011) 10: 131-142.
28. Dong J, Albertini DF, Nishimori K, Kumar TR, Lu N and Matzuk MM: Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature (1996) 383: 531-535.
29. Galloway SM, McNatty KP, Cambridge LM, Laitinen MP, Juenge JL, Jokiranta TS, McLaren RJ, Luiro K, Dodds KG, Montgomery GW, Beattie AE, Davis GH and Ritvos O: Mutations in an oocyte-derived growth factor gene (bmp15) cause increased ovulation rate and infertility in a dosage-sensitive manner. Nat Genet (2000) 25: 279-283.
30. Otsuka F, Yao Z, Lee TH, Yamamoto S, Erickson GF and Shimasaki S: Bone morphogenetic protein-15: Identification of target cells and biological functions. J Biol Chem (2000) 275: 39523-39528.
31. Otsuka F, Yamamoto S, Erickson GF and Shimasaki S: Bone morphogenetic protein-15 inhibits follicle-stimulating hormone (fsh) action by suppressing fsh receptor expression. J Biol Chem (2001) 276: 11387-11392.
32. Wilson T, Wu X-Y, Juengel JL, Ross IK, Lumsden JM, Lord EA: Dodds KG, Walling GA, McEwan JC, O'Connell AR, McNatty KP and Montgomery GW: Highly prolific booroola sheep have a mutation in the intracellular kinase domain of bone morphogenetic protein ib receptor (alk-6) that is expressed in both oocytes and granulosa cells. Biol Reprod (2001) 64: 1225-1235.
33. Mulsant P, Lecerf F, Fabre S, Schibler L, Monget P, Lanneluc I Pisselet C, Riquet J, Monniaux D, Callebaut I, Cribiu E: Thimonier J, Teyssier J, Bodin L, Cognie Y, Chitour N and Elsen JM: Mutation in bone morphogenetic protein receptor-ib is associated with increased ovulation rate in booroola merino ewes. Proc Natl Acad Sci U S A (2001) 98: 5104-5109.
34. SouzaCJH, MacDougall C, Campbell BK, McNeilly AS and Baird DT: The booroola (fecb) phenotype is associated with a mutation in the bone morphogenetic receptor type 1 b (bmprlb) gene. J Endocrinol (2001) 169: R1-R6.
35. McNatty KP, Kieboom LE, McDiarmid J, Heath DA and Lun S: Adenosine cyclic 3', 5'-monophosphate and steroid production by small ovarian follicles from booroola ewes with and without a fecundity gene. J Reprod Fertil (1986) 76: 471-480.
36. Moore RK, Otsuka F and Shimasaki S: Molecular basis of bone morphogenetic protein-15 signaling in granulosa cells. J Biol Chem (2003)278: 304-310.
37. Otsuka F, Moore RK and Shimasaki S: Biological function and cellular mechanism of bone morphogenetic protein-6 in the ovary. J Biol Chem (2001) 276: 32889-32895.
38. Shimasaki S, Zachow RJ, Li D, Kim H, lemura S, Ueno N Sampath K, Chang RJ and Erickson GF: A functional bone morphogenetic protein system in the ovary. Proc Natl Acad Sci U S A (1999)96: 7282-7287.
39. Lee W, Otsuka F, Moore RK and Shimasaki S: Effect of bone morphogenetic protein-7 on folliculogenesis and ovulation in the rat. Biol Reprod (2001) 65: 994-999.
40. Miyoshi T, Otsuka F, Inagaki K, Otani H, Takeda M, Suzuki J Goto J, Ogura T and Makino H: Differential regulation of steroido-genesis by bone morphogenetic proteins in granulosa cells Involvement of extracellularly regulated kinase signaling and oocyte actions in follicle-stimulating hormone-induced estrogen production. Endocrinology (2007) 148: 337-345.
41. Inagaki K, Otsuka F, Miyoshi T, Yamashita M, Takahashi M Goto J, Suzuki J and Makino H: P38-mitogen-activated protein kinase stimulated steroidogenesis in granulosa cell-oocyte cocultures: Role of bone morphogenetic proteins 2 and 4. Endocrinology (2009) 150: 1921-1930.
42. Otsuka F, Moore RK, lemura S-l, Ueno N and Shimasaki S Follistatin inhibits the function of the oocyte-derived factor bmp-15. Biochem Biophys Res Commun (2001) 289: 961-966.
43. Miyoshi T, Otsuka F, Suzuki J, Takeda M, Inagaki K, Kano Y. Otani H, Mimura Y, Ogura T and Makino H: Mutual regulation of follicle-stimulating hormone signaling and bone morphogenetic protein system in human granulosa cells. Biol Reprod (2006) 74: 1073-1082.
44. Otsuka F and Shimasaki S: A negative feedback system between oocyte bone morphogenetic protein 15 and granulosa cell kit igand: Its role in regulating granulosa cell mitosis. Proc Natl Acad Sci USA (2002) 99: 8060-8065.
45. Driancourt MA, Reynaud K, Cortvrindt R and Smitz J: Roles of kit and kit ligand in ovarian function. Rev Reprod (2000) 5: 143-152
46. Hutt KJ, McLaughlin EA and Holland MK: Kit ligand and c-kit have diverse roles during mammalian oogenesis and folliculogenesis. Mol Hum Reprod (2006) 12: 61-69.
47. Thomas FH and Vanderhyden BC: Oocyte-granulosa cell interactions during mouse follicular development: Regulation of kit ligand expression and its role in oocyte growth. Reprod Biol Endocrinol (2006)4: 19.
48. Joyce IM, Clark AT, Pendola FL and Eppig JJ: Comparison of recombinant growth differentiation factor-9 and oocyte regulation of kit ligand messenger ribonucleic acid expression in mouse ovarian follicles. Biol Reprod (2000) 63: 1669-1675.
49. Miyoshi T, Otsuka F, Nakamura E, Inagaki K, Ogura-Ochi K: Tsukamoto N, Takeda M and Makino H: Regulatory role of kit igand-c-kit interaction and oocyte factors in steroidogenesis by rat granulosa cells. Mol Cell Endocrinol (2012) 358: 18-26
50. McGrath SA, Esquela AF and Lee S-J: Oocyte-specific expression of growth/differentiation factor-9. Mol Endocrinol (1995) 9: 131-136.
51. Dube JL, Wang P, Elvin J, Lyons KM, Celeste AJ and Matzuk MM: The bone morphogenetic protein 15 gene is x-linked and expressed in oocytes. Mol Endocrinol (1998) 12: 1809-1817.
52. Liao WX, Moore RK, Otsuka F and Shimasaki S: Effect of intracellular interactions on the processing and secretion of bone morphogenetic protein-15 (bmp-15) and growth and differentiation fac-tor-9. Implication of the aberrant ovarian phenotype of bmp-15 mutant sheep. J Biol Chem (2003) 278: 3713-3719.
53. Liao WX, Moore RK and Shimasaki S: Functional and molecular characterization of naturally occurring mutations in the oocyte-secreted factors bone morphogenetic protein-15 and growth and differentiation factor-9. J Biol Chem (2004) 279: 17391-17396.
54. McMahon HE, Sharma S and Shimasaki S: Phosphorylation of bone morphogenetic protein-15 and growth and differentiation factor- 9 plays a critical role in determining agonistic or antagonistic functions. Endocrinology (2008) 149: 812-817.
55. Miyoshi T, Otsuka F, Yamashita M, Inagaki K, Nakamura E. Tsukamoto N, Takeda M, Suzuki J and Makino H: Functional relationship between fibroblast growth factor-8 and bone morphogenetic proteins in regulating steroidogenesis by rat granulosa cells. Mol Cell Endocrinol (2010) 325: 84-92
56. Sugiura K, Su YQ, Li Q, Wigglesworth K, Matzuk MM and Eppig JJ: Fibroblast growth factors and epidermal growth factor cooperate with oocyte-derived members of the tgfbeta superfamily to regulate spry2 mrna levels in mouse cumulus cells. Biol Reprod (2009) 81: 833-841.
57. Scully KM and Rosenfeld MG: Pituitary development: Regulatory codes in mammalian organogenesis. Science (2002) 295: 2231-2235.
58. Dasen JS and Rosenfeld MG: Signaling and transcriptional mechanisms in pituitary development. Annu Rev Neurosci (2001) 24: 327-355.
59. Kioussi C, Carriere C and Rosenfeld MG: A model for the development of the hypothalamic-pituitary axis: Transcribing the hypophysis. Mech Dev (1999) 81: 23-35
60. Suga H, Kadoshima T, Minaguchi M, Ohgushi M, Soen M Nakano T, Takata N, Wataya T, Muguruma K, Miyoshi H Yonemura S, Oiso Y and Sasai Y: Self-formation of functional adenohypophysis in three-dimensional culture. Nature (2011) 480 57-62.
61. Giacomini D, Paez-Pereda M, Theodoropoulou M, Gerez J. Nagashima AC, Chervin A, Berner S, Labeur M, Refojo D Renner U, Stalla GK and Arzt E: Bone morphogenetic protein-4 control of pituitary pathophysiology. Front Horm Res (2006) 35: 22-31.
62. Labeur M, Paez-Pereda M, Haedo M, Arzt E and Stalla GK Pituitary tumors: Cell type-specific roles for bmp-4. Mol Cell Endocrinol (2010) 326: 85-88.
63. Paez-Pereda M, Giacomini D, Refojo D, Nagashima AC, Hopfner U, Grubler Y, Chervin A, Goldberg V, Goya R, Hentges ST, Low MJ, Holsboer F, Stalla GK and Arzt E: Involvement of bone morphogenetic protein 4 (bmp-4) in pituitary prolactinoma pathogenesis through a smad/estrogen receptor crosstalk. Proc Natl Acad Sci U S A (2003) 100: 1034-1039.
64. Giacomini D, Paez-Pereda M, Stalla J, Stalla GK and Arzt E Molecular interaction of bmp-4, tgf-beta, and estrogens in lactotrophs: Impact on the prl promoter. Mol Endocrinol (2009) 23: 1102-1114.
65. Miyoshi T, Otsuka F, Otani H, Inagaki K, Goto J, Yamashita M Ogura T, Iwasaki Y and Makino H: Involvement of bone morphogenetic protein-4 in gh regulation by octreotide and bromocriptine in rat pituitary gh3 cells. J Endocrinol (2008) 197: 159-169.
66. Otsuka F, Tsukamoto N, Miyoshi T, Iwasaki Y and Makino H: Bmp action in the pituitary: Its possible role in modulating somatostatin sensitivity in pituitary tumor cells. Mol Cell Endocrinol (2012) 349: 105-110.
67. Shimon I, Yan X, Taylor JE, Weiss MH, Culler MD and Melmed S: Somatostatin receptor (sstr) subtype-selective analogues differentially suppress in vitro growth hormone and prolactin in human pituitary adenomas. Novel potential therapy for functional pituitary tumors. J Clin Invest (1997) 100: 2386-2392
68. Reisine T and Bell Gl: Molecular biology of somatostatin receptors. Endocr Rev (1995) 16: 427-442
69. Tsukamoto N, Otsuka F, Miyoshi T, Inagaki K, Nakamura E: Suzuki J, Ogura T, Iwasaki Y and Makino H: Activities of bone morphogenetic proteins in prolactin regulation by somatostatin analogs in rat pituitary gh3 cells. Mol Cell Endocrinol (2011) 332: 163-169.
70. Casanueva FF, Molitch ME, Schlechte JA, Abs R, Bonert V: Bronstein MD, Brue T, Cappabianca P, Colao A, Fahlbusch R Fideleff H, Hadani M, Kelly P, Kleinberg D, Laws E, Marek J Scanlon M, Sobrinho LG, Wass JA and Giustina A: Guidelines of the pituitary society for the diagnosis and management of prolacti-nomas. Clin Endocrinol (Oxf) (2006) 65: 265-273.
71. Missale C, Nash SR, Robinson SW, Jaber M and Caron MG Dopamine receptors: From structure to function. Physiol Rev (1998) 78: 189-225.
72. Molitch ME: Pharmacologic resistance in prolactinoma patients. Pituitary (2005) 8: 43-52.
73. Gillam MP, Molitch ME, Lombardi G and Colao A: Advances in the treatment of prolactinomas. Endocr Rev (2006) 27: 485-534.
74. Hofland LJ, Feelders RA, de Herder WW and Lamberts SW Pituitary tumours: The sst/d2 receptors as molecular targets. Mol Cell Endocrinol (2011) 326: 89-98.
75. Jaquet P, Ouafik L, Saveanu A, Gunz G, Fina F, Dufour H Culler MD, Moreau JP and Enjalbert A: Quantitative and functional expression of somatostatin receptor subtypes in human prolactinomas. J Clin Endocrinol Metab (1999) 84: 3268-3276.
76. Hofland LJ, van der Hoek J, van Koetsveld PM, de Herder WW: Waaijers M, Sprij-Mooij D, Bruns C, Weckbecker G, Feelders R van der Lely AJ, Beckers A and Lamberts SW: The novel somatostatin analog som230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitro. J Clin Endocrinol Metab (2004) 89: 1577-1585.
77. Tsukamoto N, Otsuka F, Miyoshi T, Yamanaka R, Inagaki K: Yamashita M, Otani H, Takeda M, Suzuki J, Ogura T, Iwasaki Y and Makino H: Effects of bone morphogenetic protein (bmp) on adrenocorticotropin production by pituitary corticotrope cells hvolvement of up-regulation of bmp receptor signaling by somatostatin analogs. Endocrinology (2010) 151: 1129-1141.
78. Tsukamoto N, Otsuka F, Miyoshi T, Inagaki K, Nakamura E: Terasaka T, Takeda M, Ogura T, Iwasaki Y and Makino H Functional interaction of bone morphogenetic protein and growth hormone releasing peptide in adrenocorticotropin regulation by corticotrope cells. Mol Cell Endocrinol (2011) 344: 41-50.
79. Puente E, Saint-Laurent N, Torrisani J, Furet C, Schally AV: Vaysse N, Buscail L and Susini C: Transcriptional activation of mouse sst2 somatostatin receptor promoter by transforming growth factor-beta. Involvement of smad4. J Biol Chem (2001) 276: 13461-13468.
80. Otani H, Otsuka F, Inagaki K, Suzuki J and Makino H: Roles of bone morphogenetic protein-6 in aldosterone regulation by adreno-cortical cells. Acta Med Okayama (2010) 64: 213-218.
81. Suzuki J, Otsuka F, Inagaki K, Takeda M, Ogura T and Makino H Novel action of activin and bone morphogenetic protein in regulat-ing aldosterone production by human adrenocortical cells. Endocrinology (2004) 145: 639-649.
82. Inagaki K, Otsuka F, Suzuki J, Kano Y, Takeda M, Miyoshi T. Otani H, Mimura Y, Ogura T and Makino H: Involvement of bone morphogenetic protein-6 in differential regulation of aldosterone production by angiotensin ii and potassium in human adrenocorti-cal cells. Endocrinology (2006) 147: 2681-2689.
83. Otani H, Otsuka F, Inagaki K, Suzuki J, Miyoshi T, Kano Y. Goto J, Ogura T and Makino H: Aldosterone breakthrough caused by chronic blockage of angiotensin ii type 1 receptors in human adrenocortical cells: Possible involvement of bone morphogenetic protein-6 actions. Endocrinology (2008) 149: 2816-2825.
84. Matsumoto Y, Otsuka F, Inagaki K, Tsukamoto N, Takano-Narazaki M, Miyoshi T, Nakamura E, Ogura-Ochi K, Takeda M and Makino H: An in vivo role of bone morphogenetic protein-6 in aldosterone production by rat adrenal gland. J Steroid Biochem Mol Biol (2012) 132: 8-14.
85. Bornstein SR, Gonzalez-Hernandez JA, Ehrhart-Bornstein M Adler G and Scherbaum WA: Intimate contact of chromaffin and cortical cells within the human adrenal gland forms the cellular basis for important intraadrenal interactions. J Clin Endocrinol Metab(1994) 78: 225-232.
86. Schinner S and Bornstein SR: Cortical-chromaffin cell interactions in the adrenal gland. Endocr Pathol (2005) 16: 91-98
87. Wurtman RJ, Pohorecky LA, Baliga BS: Adrenocortical control of the biosynthesis of epinephrine and proteins in the adrenal medulla. Pharmacol Rev (1972) 24: 411-426.
88. Kano Y, Otsuka F, Takeda M, Suzuki J, Inagaki K, Miyoshi T. Miyamoto M, Otani H, Ogura T and Makino H: Regulatory roles of bone morphogenetic proteins and glucocorticoids in catecholamine production by rat pheochromocytoma cells. Endocrinology (2005) 146: 5332-5340.
89. Mehler MF, Mabie PC, Zhang D and Kessler JA: Bone morphogenetic proteins in the nervous system. Trends Neurosci (1997) 20: 309-317.
90. Reissmann E, Ernsberger U, Francis-West PH, Rueger D, Brickel PM and Rohrer H: Involvement of bone morphogenetic protein-4 and bone morphogenetic protein-7 in the differentiation of the adrenergic phenotype in developing sympathetic neurons. Development (1996) 122: 2079-2088.
91. Varley JE, Wehby RG, Rueger DC and Maxwell GD: Number of adrenergic and islet-1 immunoreactive cells is increased in avian trunk neural crest cultures in the presence of human recombinant osteogenic protein-1. Dev Dyn (1995) 203: 434-447.
92. Varley JE and Maxwell GD: Bmp-2 and bmp-4, but not bmp-6: increase the number of adrenergic cells which develop in quai trunk neural crest cultures. Exp Neural (1996) 140: 84-94.
93. Goto J, Otsuka F, Yamashita M, Suzuki J, Otani H, Takahashi H Miyoshi T, Mimura Y, Ogura T and Makino H: Enhancement of aldosterone-induced catecholamine production by bone morphogenetic protein-4 through activating rho and sapk/jnk pathway in adrenomedullar cells. Am J Physiol Endocrinol Metab (2009) 296: E904-916.
94. Di Pasquale E, Beck-Peccoz P and Persani L: Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (bmp15) gene. Am J Hum Genet (2004) 75: 106-111.
95. Di Pasquale E, Rossetti R, Marozzi A, Bodega B, Borgato S. Cavallo L, Einaudi S, Radetti G, Russo G, Sacco M, Wasniewska M, Cole T, Beck-Peccoz P, Nelson LM and Persani L: Identification of new variants of human bmp15 gene in a large cohort of women with premature ovarian failure. J Clin Endocrinol Metab (2006) 91: 1976-1979.
96. Dixit H, Rao LK, Padmalatha VV, Kanakavalli M, Deenadayal M Gupta N, Chakrabarty B and Singh L: Missense mutations in the bmp15 gene are associated with ovarian failure. Hum Genet (2006) 119: 408-415.
97. Laissue P, Christin-Maitre S, Touraine P, Kuttenn F, Ritvos O Aittomaki K, Bourcigaux N, Jacquesson L, Bouchard P, Frydman R, Dewailly D, Reyss AC, Jeffery L, Bachelot A, Massin N. Fellous M and Veitia RA: Mutations and sequence variants in gdf9 and bmp15 in patients with premature ovarian failure. Eur J Endocrinol (2006) 154: 739-744.
98. Nakamura E, Otsuka F, Inagaki K, Miyoshi T, Matsumoto Y. Ogura K, Tsukamoto N, Takeda M and Makino H: Mutual regulation of growth hormone and bone morphogenetic protein system in steroidogenesis by rat granulosa cells. Endocrinology (2012) 153: 469-480.
99. Nakamura E, Otsuka F, Inagaki K, Miyoshi T, Yamanaka R Tsukamoto N, Suzuki J, Ogura T and Makino H: A novel antagonistic effect of the bone morphogenetic protein system on prolactin actions in regulating steroidogenesis by granulosa cells. Endocrinology (2010) 151: 5506-5518.
100. Lamberts SW and Hofland LJ: Future treatment strategies of aggressive pituitary tumors. Pituitary (2009) 12: 261-264.